DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
18.16
-0.25 (-1.36%)
May 13, 2025, 2:45 PM CST

SHA:603233 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
976.3914.751,1661,036791.231,062
Upgrade
Depreciation & Amortization
1,5841,5841,4481,2881,149170.77
Upgrade
Other Amortization
311.36311.36248.28243.75218.08169.03
Upgrade
Loss (Gain) From Sale of Assets
-19.21-19.21-3.43-18.73-5.632.53
Upgrade
Asset Writedown & Restructuring Costs
38.638.66.21---
Upgrade
Loss (Gain) From Sale of Investments
-11.57-11.57-10.9412.89-44-20.91
Upgrade
Provision & Write-off of Bad Debts
15.2815.2815.9223.611.495.6
Upgrade
Other Operating Activities
827.53347.74388.19294.24247.4955.02
Upgrade
Change in Accounts Receivable
-1,588-1,588-364.73-953.44-317.98-75.05
Upgrade
Change in Inventory
126.08126.08-104.16-157.39-745.93-539.61
Upgrade
Change in Accounts Payable
1,3951,395389.071,967235.181,113
Upgrade
Change in Other Net Operating Assets
3.283.2819.0448.5465.6314.45
Upgrade
Operating Cash Flow
3,6483,1063,1743,7571,5551,954
Upgrade
Operating Cash Flow Growth
-0.01%-2.13%-15.51%141.58%-20.42%14.41%
Upgrade
Capital Expenditures
-1,259-1,476-1,797-1,035-1,295-792.32
Upgrade
Sale of Property, Plant & Equipment
29.1328.5314.6437.3721.6112.35
Upgrade
Cash Acquisitions
-387.65-520.82-502.3-305.25-529.82-289.75
Upgrade
Divestitures
1.591.59----
Upgrade
Investment in Securities
0.3111.34-2.165.54814.11-19.16
Upgrade
Other Investing Activities
15.2615.86-11.83.1721.3517.64
Upgrade
Investing Cash Flow
-1,600-1,939-2,303-1,294-967.7-1,071
Upgrade
Short-Term Debt Issued
-191.8816--1,570
Upgrade
Long-Term Debt Issued
-3,1371,0941,095145.63-
Upgrade
Total Debt Issued
3,1443,3291,1101,095145.631,570
Upgrade
Short-Term Debt Repaid
---4.9---118.8
Upgrade
Long-Term Debt Repaid
--3,422-2,388-1,655-1,321-
Upgrade
Total Debt Repaid
-3,912-3,422-2,392-1,655-1,321-118.8
Upgrade
Net Debt Issued (Repaid)
-767.65-92.44-1,282-560.15-1,1751,451
Upgrade
Issuance of Common Stock
----13.25100.01
Upgrade
Repurchase of Common Stock
-101.8-101.8-0.95-0.11-0.44-
Upgrade
Common Dividends Paid
-760.26-753.21-604.51-420.29-534.28-333.27
Upgrade
Other Financing Activities
33.3915.52238.1546.9884.37-8.41
Upgrade
Financing Cash Flow
-1,596-931.93-1,649-933.57-1,6121,209
Upgrade
Foreign Exchange Rate Adjustments
0.320.32----
Upgrade
Net Cash Flow
451.76235.37-778.781,529-1,0252,092
Upgrade
Free Cash Flow
2,3891,6301,3772,722260.051,162
Upgrade
Free Cash Flow Growth
16.57%18.39%-49.40%946.64%-77.61%-3.71%
Upgrade
Free Cash Flow Margin
8.95%6.15%5.61%12.81%1.55%7.96%
Upgrade
Free Cash Flow Per Share
2.111.441.222.390.231.02
Upgrade
Cash Income Tax Paid
1,3201,2681,108939.01897.77846.9
Upgrade
Levered Free Cash Flow
2,5902,0782,2612,191412.54740.11
Upgrade
Unlevered Free Cash Flow
2,7392,2342,4112,336545.07747.29
Upgrade
Change in Net Working Capital
-1,093-844.06-1,370-804.95281.16-333.76
Upgrade
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.